We are live on
!
Find out more
&Partners Portfolio holdings
AUM
$24.4B
Turnover
11.02%
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter
Est. Return
-0.17%
1 Year Est. Return
+27.45%
3 Year Est. Return
+78.37%
5 Year Est. Return
+81.51%
10 Year Est. Return
–
AUM
$20.2B
AUM Growth
+$1.12B
(+5.8%)
Cap. Flow
+$1.5B
Cap. Flow
% of AUM
7.39%
Top 10 Holdings %
Top 10 Hldgs %
21.52%
Holding
2,502
New
219
Increased
1,362
Reduced
773
Closed
107
Avg Time Held
1.4
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$77.2M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$54.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$52.1M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$47.3M |
| 5 |
Microsoft
MSFT
|
+$36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nextpower Inc. Common Stock
NXT
|
+$27.5M |
| 2 |
First Trust NASDAQ Technology Dividend Index Fund
TDIV
|
+$16.2M |
| 3 |
First Trust Utilities AlphaDEX Fund
FXU
|
+$11.5M |
| 4 |
iShares US Financials ETF
IYF
|
+$11.4M |
| 5 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.29% |
| 2 | Technology | 16.28% |
| 3 | Financials | 7.94% |
| 4 | Industrials | 5.61% |
| 5 | Healthcare | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.23B
| $3.39M | 0.02% |
33,201
-2,095
| -6% | -$220K |
2024 Q2
7 quarters
|
|
677
VanEck Emerging Markets High Yield Bond ETF
HYEM
$512M
| $3.39M | 0.02% |
171,488
+4,248
| +3% | +$85.1K |
2024 Q3
6 quarters
|
|
678
lululemon athletica
LULU
$11.5B
| $3.38M | 0.02% |
22,169
+2,041
| +10% | +$366K |
2024 Q2
7 quarters
|
|
679
CAVA Group
CAVA
$6.47B
| $3.38M | 0.02% |
41,908
+402
| +1% | +$29.3K |
2024 Q2
7 quarters
|
|
680
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.71B
| $3.37M | 0.02% |
75,457
-53,257
| -41% | -$2.42M |
2024 Q2
7 quarters
|
|
681
Brookfield
BN
$82.2B
| $3.35M | 0.02% |
82,847
-2,660
| -3% | -$118K |
2024 Q2
7 quarters
|
|
682
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$335M
| $3.35M | 0.02% |
+208,680
| New | +$3.66M |
2026 Q1
0 quarters
|
|
683
Invesco Aerospace & Defense ETF
PPA
$7.56B
| $3.35M | 0.02% |
20,221
+1,809
| +10% | +$316K |
2024 Q1
8 quarters
|
|
684
Vanguard World Funds Extended Duration ETF
EDV
$3.75B
| $3.34M | 0.02% |
51,498
+4,383
| +9% | +$290K |
2024 Q3
6 quarters
|
|
685
United Therapeutics
UTHR
$23.2B
| $3.33M | 0.02% |
5,510
+2,072
| +60% | +$1.03M |
2024 Q3
6 quarters
|
|
686
PGIM Total Return Bond ETF
PTRB
$1.16B
| $3.33M | 0.02% |
80,289
+73,211
| +1,034% | +$3.08M |
2025 Q2
3 quarters
|
|
687
Canadian Natural Resources
CNQ
$107B
| $3.32M | 0.02% |
68,124
+13,183
| +24% | +$542K |
2025 Q1
4 quarters
|
|
688
iShares Biotechnology ETF
IBB
$10.6B
| $3.31M | 0.02% |
19,624
+413
| +2% | +$70.6K |
2018 Q4
29 quarters
|
|
689
GSK
GSK
$98.2B
| $3.31M | 0.02% |
60,115
-33,190
| -36% | -$1.8M |
2024 Q1
8 quarters
|
|
690
iShares S&P Small-Cap 600 Value ETF
IJS
$7.55B
| $3.3M | 0.02% |
27,920
+1,760
| +7% | +$213K |
2024 Q2
7 quarters
|
|
691
Houlihan Lokey
HLI
$8.98B
| $3.3M | 0.02% |
22,976
-363
| -2% | -$59.7K |
2024 Q2
7 quarters
|
|
692
iShares MSCI ACWI ex US ETF
ACWX
$17.5B
| $3.29M | 0.02% |
48,067
+34,143
| +245% | +$2.41M |
2025 Q3
2 quarters
|
|
693
Principal Spectrum Preferred Securities Active ETF
PREF
$1.89B
| $3.29M | 0.02% |
175,575
+71,788
| +69% | +$1.37M |
2024 Q2
7 quarters
|
|
694
Cardinal Health
CAH
$58.7B
| $3.28M | 0.02% |
15,563
+2,299
| +17% | +$495K |
2024 Q3
6 quarters
|
|
695
Moelis & Co
MC
$4.1B
| $3.28M | 0.02% |
57,443
+4,452
| +8% | +$289K |
2024 Q2
7 quarters
|
|
696
PACCAR
PCAR
$58.3B
| $3.27M | 0.02% |
28,307
-2,603
| -8% | -$315K |
2024 Q1
8 quarters
|
|
697
FS KKR Capital
FSK
$2.97B
| $3.26M | 0.02% |
321,034
-33,673
| -9% | -$421K |
2025 Q4
1 quarter
|
|
698
AB InBev
BUD
$160B
| $3.23M | 0.02% |
46,688
-286
| -0.6% | -$20.6K |
2023 Q4
9 quarters
|
|
699
Performance Food Group
PFGC
$15.3B
| $3.23M | 0.02% |
37,339
+8,905
| +31% | +$814K |
2022 Q3
14 quarters
|
|
700
Equifax
EFX
$18.9B
| $3.23M | 0.02% |
17,852
+1,112
| +7% | +$221K |
2022 Q4
13 quarters
|
|
Similar funds
&Partners's Q1 2026 Portfolio in Review
As of Q1 2026, &Partners held 2,502 positions worth $20.2B, up 5.8% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
&Partners deployed $1.5B of net new capital in Q1 2026, opening 219 new positions and adding to 1,362 existing holdings. Its largest new stake was First Trust Nasdaq Transportation ETF: 367,478 shares worth $14M.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Nextpower Inc. Common Stock, an estimated $27.5M trimmed.
- &Partners's largest Q1 2026 buy was First Trust Nasdaq Transportation ETF: 367,478 shares worth $14M.
- &Partners added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $77.2M increase.
- &Partners's biggest Q1 2026 reduction was Nextpower Inc. Common Stock, cutting an estimated $27.5M.
- &Partners fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2026, selling an estimated $2.96M.
- &Partners's ten largest holdings make up 22% of its $20.2B portfolio in Q1 2026.
- &Partners opened 219 new positions and closed 107 in Q1 2026.
- &Partners's portfolio value rose 5.8% quarter-over-quarter to $20.2B.
Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.